Analysis of MAGE-3-specific cytolytic T lymphocytes in human leukocyte antigen-A2 melanoma patients

Cancer Research

Volumn 57, Issue 4, 1997, Pages 735-741

  Valmori, Danila ^a   Liénard, Danielle ^a,b   Waanders, Gary ^a   Rimoldi, Donata ^a   Cerottini, Jean Charles ^a   Romero, Pedro ^a,c  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b Pluridisciplinary Center of Oncology   (Switzerland)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; AMINO ACID SEQUENCE; ANALYTIC METHOD; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; CYTOTOXIC T LYMPHOCYTE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNIZATION; MELANOMA; MULTIGENE FAMILY; PRIORITY JOURNAL; STEM CELL; TARGET CELL; TUMOR ASSOCIATED LEUKOCYTE;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; HLA-A2 ANTIGEN; HUMANS; IMMUNOTHERAPY; LEUKOCYTES; MELANOMA; MIDDLE AGED; NEOPLASM PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 1842296989     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. De Plaen, E., Arden, K., Traversari, C., Gaforio, J. J., Szikora, J. P., De Smet, C., Brasseur, F., van der Bruggen, P., Lethé, B., Lurquin, C., Brasseur, R., Chomez, P., de Backer, O., Cazenave, W., and Boon, T. Structure, chromosomal localization and expression of 12 genes of the MAGE family. Immunogenetics, 40: 360-369, 1994.
2. Brasseur, R, Rimoldi, D., Liénard, D., Lethé, B., Carrel, S., Arienti, F., Suter, L., Vanwijck, R., Bourlond, A., Humblet, Y., Vacca, A., Conese, M., Lahaye, T., Degiovanni, G., Deraemaecker, R., Beauduin, M, Sastre, X., Salamon, E., Dréno, B., Jäger, E., Knuth, A., Chevreau, C., Suciu, S., Lachapelle, J. M., Fouillait, P., Parmiani, G., Lejeune, F., Cerottini, J. C., Boon, T., and Marchand, M. Expression of MAGE genes in primary and metastatic cutaneous melanoma. Int. J. Cancer, 63: 375-380, 1995.
3. Van Pel, A., van der Bruggen, P., Coulie, P. G., Brichard, V. G., Lethé, B., Van den Eynde, B., Uyttenhove, C., Renauld, J. C., and Boon, T. Genes coding for tumor antigens recognized by cytolytic T lymphocytes. Immunol. Rev., 145: 229-250, 1995.
4. Boon, T., Cerottini, J. C., Van den Eynde, B., van der Bruggen, P., and Van Pel, A. Tumor antigens recognized by T lymphocytes. Annu. Rev. Immunol., 12: 337-365, 1994.
5. Traversari, C., van der Bruggen, P., Luescher, I. F., Lurquin, C., Chomez, P., Van Pel, A., De Plaen, E., Amar-Costesec, A., and Boon, T. A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J. Exp. Med., 176: 1453-1457, 1992.
6. Gaugler, B., Van den Eynde, B., van der Bruggen, P., Romero, P., Gaforio, J. J., De Plaen, E., Lethé, B., Brasseur, F., and Boon, T. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J. Exp. Med., 179:921-930, 1994.
7. Falk, K., Rötzschke, O., Stevanovic, S., Jung, G., and Rammensee. H. G. Allelespecific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature (Lond.), 351: 290-296, 1991.
8. Madden, D. R., Gorga, J. C., Strominger, J. L., and Wiley, D. C. The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation. Nature (Lond.), 353: 321-325, 1991.
9. Engelhard, V. H. Structure of peptides associated with class I and class II MHC molecules. Annu. Rev. Immunol., 12: 181-287, 1994.
10. Rammensee, H. G., Friede, T., and Stevanovic, S. MHC ligands and peptide motifs: first listing. Immunogenetics, 41: 178-228, 1995.
11. Celis, E., Fikes, J., Wentworth, P., Sidney, J., Southwood, S., Maewal, A., Dei Guercio, M. F., Sette, A., and Livingston, B. Identification of potential CTL epitopes of tumor-associated antigen MAGE-1 for five common HLA-A alleles. Mol. Immunol., 31: 1423-1430, 1994.
12. Kubo, R. T., Sette, A., Grey, H. M., Appella, E., Sakaguchi, K., Zhu, N. Z., Arnott, D., Shermun, N., Shabanowitz, J., Michel, H. Definition of specific peptide motifs for four major HLA-A alleles. J. Immunol., 152: 3913-3924, 1994.
13. Elvin, J., Potter, C., Elliott, T., Cerundolo, V., and Townsend, A. A method to quantify binding of unlabeled peptides to class I MHC molecules and detect their allele specificity. J. Immunol. Methods, 158: 161-171, 1993.
14. Luescher, I. F., Romero, P., Kuznetsov, D., Rimoldi, D., Coulie, P., Cerottini, J. C., and Jongeneel, C. V. HLA photoaffinity labeling reveals overlapping binding of homologous MAGE peptides by HLA-A1, HLA-29 and HLA-B44. J. Biol. Chem., in press, 1996.
15. Nijman, H. W., Houbiers, J. G., Vierboom, M. P., van der Burg, S. H., Drijfhout, J. W., D'Amaro, J., Kenemans, P., Melief, C. J., and Kast, W. M. Identification of peptide sequences that potentially trigger HLA-A2.1-restricted cytotoxic T lymphocytes. Eur. J. Immunol., 23: 1215-1219, 1993.
16. van der Bruggen, P., Bastin, J., Gajewski, T., Coulie, P., Boël, P., De Smet, C., Traversari, C., Townsend, A., and Boon, T. A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Eur. J. Immunol., 24: 3038-3043, 1994.
17. Imanishi, T., Akaza, A., Kimura, A., Tokunaga, K., and Gojobori, T. Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. In: HLA 1991, p. 1066. Tokyo: Oxford University Press, 1992.
18. Atherton, E., Logan, C. J., and Sheppard, R. C. Peptide synthesis. Part 2. Procedures for solid phase synthesis using Na-fluorenylmethoxycarbamylamino-acid on polyamide supports. Synthesis of substance P and of acyl carrier protein 65-74 decapeptide. J. Chem. Soc. Perkin Trans. I. 1: 538-543, 1981.
19. Wentworth, P. A., Celis, E., Crimi, C., Stitely. S., Hale, L., Tsai, V., Serra, H. M., Del Guercio, M. F., Livingston, B., Alazard, D., Fikes, J., Kubo, R. T., Grey, H. M., Chesnut, R. W., Chisari, F. V., and Sette, A. In vitro induction of primary, antigen- specific CTL from human peripheral blood mononuclear cells stimulated with synthetic peptides. Mol. Immunol., 32: 603-612, 1995.
20. Salter, R. D., Howell, D. N., and Cresswell, P. Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids. Immunogenetics, 21: 235-246, 1985.
21. Traversari, C., van der Bruggen, P., van der Eynde, B., Hainaut, P., Lemoine, C., Ohta, N., Old, L. J., and Boon, T. Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes, Immunogenetics, 35: 145-152, 1992.
22. Espevik, T., and Nissen-Meyer, J. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Methods, 95: 99-105, 1986.
23. Hansen, M. B., Nielsen, S. E., and Berg, K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods, 119: 203-210, 1989.
24. Langlade-Demoyen. P., Levraud, J. P., Kourilsky, P., and Abastado, J. P. Primary cytotoxic T lymphocyte induction using peptide-stripped autologous cells. Int. Immunol., 6: 1759-1766, 1994.
25. Kocher, T., Schultz-Thater, E., Gudat, F., Schaefer, C., Casorati, G., Juretic, A., Willimann, T., Harder, F., Heberer, M., and Spagnoli, G. C. Identification and intracellular location of MAGE-3 gene product. Cancer Res., 55: 2236-2239, 1995.
26. Van den Eynde, B., and Brichard, V. G. New tumor antigens recognized by T cells. Curr. Opin. Immunol., 7: 674-681, 1995.
27. Reintgen, D. S., McCarty, K. M., Jr., Cox, E., and Seigler, H. F. Malignant melanoma in black American and white American populations: a comparative review. JAMA, 248: 1856-1859, 1982.
28. Crowley, N. J. Darrow, T. L., Quinn-Allen, M. A., and Seigler, H. F. MHC-restricted recognition of autologous melanoma by tumor-specific cytotoxic T cells. J. Immunol., 146: 1692-1699, 1991.
29. Houghton, A. N. Cancer antigens: immune recognition of self and altered self, J. Exp. Med., 180: 1-4, 1994.
30. Alderson, M. R., Sassenfeld, H. M., and Widmer, M. B. Interleukin-7 enhances cytolytic T lymphocyte generation and induces lymphokine-activated killer cells from human peripheral blood. J. Exp. Med., 172: 577-587, 1990.
31. Kos, F. J., and MÜllbacher, A. Induction of primary anti-viral cytotoxic T cells by in vitro stimulation with short synthetic peptides and interleukin-7. Eur J. Immunol., 22: 3183-3185, 1992.
32. Romero, P., Pannetier, C., Herman, J., Jongeneel, C. V., Cerottini, J. C., and Coulie, P. Multiple specificities in the repertoire of a melanoma patient's cytolytic T lymphocytes directed against tumor antigen MAGE-1.A1. J. Exp. Med., 182: 1019-1028, 1995.
33. Seed, B., and Aruffo, A. Molecular cloning of the CD2 antigen, the T-cell erythrocyte receptor, by a rapid immunoselection procedure. Proc. Natl. Acad. Sci. USA, 84: 3365-3369, 1987.